379 related articles for article (PubMed ID: 11170223)
21. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
Zackheim JA; Abercrombie ED
Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986
[TBL] [Abstract][Full Text] [Related]
22. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT.
Cook CD; Rodefer JS; Picker MJ
Psychopharmacology (Berl); 1999 Jun; 144(3):239-47. PubMed ID: 10435390
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
Bowyer JF; Weiner N
J Pharmacol Exp Ther; 1987 Apr; 241(1):27-33. PubMed ID: 3572788
[TBL] [Abstract][Full Text] [Related]
24. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
Koshikawa N; Kitamura M; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
[TBL] [Abstract][Full Text] [Related]
25. Direct and indirect actions of dopamine on the membrane potential in medium spiny neurons of the mouse neostriatum.
Yasumoto S; Tanaka E; Hattori G; Maeda H; Higashi H
J Neurophysiol; 2002 Mar; 87(3):1234-43. PubMed ID: 11877497
[TBL] [Abstract][Full Text] [Related]
26. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.
Acquas E; Di Chiara G
Eur J Pharmacol; 1999 Oct; 383(2):121-7. PubMed ID: 10585525
[TBL] [Abstract][Full Text] [Related]
27. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.
Sammut S; Bray KE; West AR
Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493
[TBL] [Abstract][Full Text] [Related]
28. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
[TBL] [Abstract][Full Text] [Related]
29. Cocaine modulates allosteric D
Beggiato S; Borelli AC; Borroto-Escuela D; Corbucci I; Tomasini MC; Marti M; Antonelli T; Tanganelli S; Fuxe K; Ferraro L
Cell Signal; 2017 Dec; 40():116-124. PubMed ID: 28923416
[TBL] [Abstract][Full Text] [Related]
30. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.
Roberts C; Cummins R; Gnoffo Z; Kew JN
Eur J Pharmacol; 2006 Mar; 534(1-3):108-14. PubMed ID: 16490190
[TBL] [Abstract][Full Text] [Related]
31. Pre-synaptic nicotinic and D receptors functionally interact on dopaminergic nerve endings of rat and mouse nucleus accumbens.
Grilli M; Zappettini S; Zoli M; Marchi M
J Neurochem; 2009 Mar; 108(6):1507-14. PubMed ID: 19166510
[TBL] [Abstract][Full Text] [Related]
32. Developmental differences in dopamine synthesis inhibition by (+/-)-7-OH-DPAT.
Andersen SL; Dumont NL; Teicher MH
Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug; 356(2):173-81. PubMed ID: 9272722
[TBL] [Abstract][Full Text] [Related]
33. Intra-accumbens infusion of D(3) receptor agonists reduces spontaneous and dopamine-induced locomotion.
Ouagazzal AM; Creese I
Pharmacol Biochem Behav; 2000 Nov; 67(3):637-45. PubMed ID: 11164096
[TBL] [Abstract][Full Text] [Related]
34. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Maj J; Rogóz Z; Skuza G
J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
[TBL] [Abstract][Full Text] [Related]
35. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
Collo G; Zanetti S; Missale C; Spano P
Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
[TBL] [Abstract][Full Text] [Related]
36. The possible involvement of dopamine D3 receptors in the regulation of gastric emptying in rats.
Yoshikawa T; Yoshida N
Life Sci; 2010 Nov; 87(19-22):638-42. PubMed ID: 20888837
[TBL] [Abstract][Full Text] [Related]
37. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
Pehek EA
J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
[TBL] [Abstract][Full Text] [Related]
38. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
[TBL] [Abstract][Full Text] [Related]
39. Role of dopamine D1 receptors in the control of striatal acetylcholine release by endogenous dopamine.
Acquas E; Di Chiara G
Neurol Sci; 2001 Feb; 22(1):41-2. PubMed ID: 11487192
[TBL] [Abstract][Full Text] [Related]
40. Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment.
Thompson TL; Bridges SR; Weirs WJ
Brain Res Bull; 2001 Apr; 54(6):631-8. PubMed ID: 11403989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
